Details of the Drug

General Information of Drug (ID: DM6NG3C)

Drug Name

CMV glycoprotein B subunit vaccine

Synonyms

CMV gB subunit vaccine, GlaxoSmithKline; CMV glycoprotein B subunit vaccine, GlaxoSmithKline; Cytomegalovirus glycoprotein B subunit vaccine, GlaxoSmithKline; GSK-1492903-A

Indication

Disease Entry	ICD 11	Status	REF
Cytomegalovirus infection	1D82	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

TTD ID: D0V6KU

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cytomegalovirus Glycoprotein B (CMV gB)	TTUR18Y	GB_HCMVA	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT00435396) Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of GlaxoSmithKline.